Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Preparation and application of drug percutaneous absorbent

A technology of transdermal absorbents and drugs, which is applied in the preparation and application of drug transdermal absorbents. It can solve the problems of limited subcutaneous tissue absorption effect and physical and mental inconvenience of patients, and achieve the effects of increasing absorption, protecting skin and repairing tissues.

Inactive Publication Date: 2016-04-06
于秀娜
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At present, antibiotics are mostly used in clinical treatment, and the absorption effect on the skin barrier and subcutaneous tissue is limited, and the ideal effect is often not achieved.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0010] Example 1: Preparation of alcohol solution: Take 0.1 part of nimodipine, 5 parts of glycerophosphate, 5 parts of safflower, and 3 parts of borneol. The preparation method is the same as above to obtain 100ml of alcohol extract.

Embodiment 2

[0011] Example 2 Preparation of ointment: Take 0.5 parts of nimodipine, 3 parts of glycerophosphate, 4 parts of safflower, and 2 parts of borneol. The preparation method is the same as in Example 1, and then the alcohol extract is dried under high pressure and concentrated to 100 g of clear paste with a relative density of 1.25-1.30 (50° C.).

[0012] Summary of clinical efficacy

[0013] 1. General information: The drug absorbent of the present invention has been clinically used for many years and has treated hundreds of patients with excellent results.

[0014] 2. Clinical indications:

[0015] 3. Efficacy judgment:

[0016] Cured: the clinical symptoms disappeared completely.

[0017] Improved: clinical symptoms improved.

[0018] Invalid: The disease cannot be controlled.

[0019] 4. Medication method: Take the alcohol extract or ointment and apply it locally, twice a day in the morning and evening, 30 minutes each time. 10 days is a course of treatment.

[0020] 5....

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to preparation and an application of a drug percutaneous absorbent. The drug percutaneous absorbent is characterized by being prepared from the following medicinal raw materials in parts by weight: 0.5-0.1 part of nimodipine, 3-5 parts of glycerophosphate, 2-5 parts of flos carthami and 1-3 parts of borneol. The drug percutaneous absorbent has the beneficial effects of protecting skin, nourishing skin, improving absorption, relieving spasm, promoting blood circulation, removing stasis, relieving pain and repairing tissue by means of the permeable membrane principle, and has small side effect and high curative effect.

Description

[0001] Technical Field The present invention relates to the preparation and application of a drug transdermal absorbent. Background technique [0002] At present, most of the drug transdermal absorption agents are made of western medicine. Because the external drug has limited absorption effect through the subcutaneous tissue, improving the drug transdermal absorption function has raised an important topic for clinical research on radiation skin damage caused by various common diseases. At present, antibiotics are mostly used in clinical treatment, and the absorption effect on the skin barrier and subcutaneous tissue is limited, and the desired effect is often not achieved. Contents of the invention [0003] The technical problem to be solved by the present invention is to provide an easy-to-use product with good transdermal absorption effect and few side effects. [0004] Beneficial effects of the skin absorbent of the present invention: the principle of permeating the memb...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/286A61P29/00A61P17/16A61K31/4422A61K31/661A61K31/045
CPCA61K31/4422A61K9/0014A61K9/06A61K9/08A61K31/045A61K31/661A61K36/286A61K2236/333A61K2236/39A61K2236/51
Inventor 于秀娜
Owner 于秀娜
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com